ArticleThe New bioethics : a multidisciplinary journal of biotechnology and the body2017
The Promise and the Hype of 'Personalised Medicine'.
Article in The New bioethics : a multidisciplinary journal of biotechnology and the body, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- External validation of a machine learning-based web application for personalized testing of objective functioning using the five-repetition sit-to-stand test.Acta neurochirurgica · 2026Article
- What Is Precision Psychotherapy?The Journal of medicine and philosophy · 2026Article
- Sorting out and navigating uncertainty in precision medicine.History and philosophy of the life sciences · 2026Article
- Ethics of Personalised Medicine: Importance of the Multidisciplinary Approach in KidneySign Project.Proteomics · 2025Article
- Te Maramataka-An Indigenous System of Attuning with the Environment, and Its Role in Modern Health and Well-Being.International journal of environmental research and public health · 2023Article
- Reimagining health services provision for neglected groups: The "personalization from below" phenomenon.Frontiers in sociology · 2023Article
- The promise of public health ethics for precision medicine: the case of newborn preventive genomic sequencing.Human genetics · 2022Review
- Public R&D Projects-Based Investment and Collaboration Framework for an Overarching South Korean National Strategy of Personalized Medicine.International journal of environmental research and public health · 2022Article
- Earth Dreams: Reimagining ARPA for Health of People, Places and Planet.International journal of environmental research and public health · 2021Article
- Prioritisation and design of clinical trials.European journal of epidemiology · 2021Article
- Hope versus reality: Parent expectations of genomic testing.Patient education and counseling · 2021Article
- Information, communication, and cancer patients' trust in the physician: what challenges do we have to face in an era of precision cancer medicine?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Article
- Accessing targeted therapies for cancer: self and collective advocacy alongside and beyond mainstream cancer charities.New genetics and society · 2021Article
- Personalized medicine, digital technology and trust: a Kantian account.Medicine, health care, and philosophy · 2020Article
- Investigating the knowledge of and public attitudes towards genetic testing within the Visegrad countries: a cross-sectional study.BMC public health · 2020Article
- A Survey Exploring Personalised Medicine amongst Radiography Academics within the United Kingdom.Journal of medical imaging and radiation sciences · 2020Article
- Community Perspectives on Communicating About Precision Medicine in an Alaska Native Tribal Health Care System.Frontiers in communication · 2020Article
- Value-based genomic screening: exploring genomic screening for chronic diseases using triple value principles.BMC health services research · 2019Article
- More than Moore's Mores: Computers, Genomics, and the Embrace of Innovation.Journal of the history of biology · 2018Article
- The 'molecularly unstratified' patient: a focus for moral, psycho-social and societal research.Biomedicine hub · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Personalised medicine is widely considered as the way of the future for medicine. However, progress in cancer, with a few outstanding exceptions, has fallen below expectations because of the challenges of tumour heterogeneity and clonal evolution. In both benign and malignant disease, diseases caused by single genetic alterations are more amenable to precision medicine approaches. However, most common diseases are caused by a complex interplay of multiple genetic and environmental factors making personalised medicine far more challenging. The current optimism for personalised medicine is distorting clinical consultations, resource allocation and research funding prioritisation. A research active clinician must act both as an agent of change and development, and as a communicator of realism. Thus personalised medicine that includes a sober appreciation of what genomics can achieve, together with continued focus on the individual as a person not just as a genome, will contribute to further improvements in health and healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.